GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a remarkable development in how we handle type 2 diabetes . These new drugs work by stimulating the body’s inherent GLP-1 substance , which https://getidealist.com/story23646120/glp-1-a-major-advance-in-blood-sugar-treatment